Erratum: Anticancer drug development: preclinical screening, clinical trials and approval

被引：0
|
作者：
B A Teicher
D L Selwood
P A Andrews
机构：
来源：
British Journal of Cancer | 2004年 / 91卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Correction to: British Journal of Cancer (2004) 91, 1000. doi:10.1038/sj.bjc.6602070 Due to an error, the ISBN number of the book reviewed above was given incorrectly. The correct number is shown below: ISBN – 1588292282.
引用
收藏
页码：1977 / 1977
相关论文
共 50 条
  • [41] Anticancer effect of bisphosphonates: new insights from clinical trials and preclinical evidence
    Daniele, Gennaro
    Giordano, Pasqualina
    De Luca, Antonella
    Piccirillo, Maria Carmela
    Di Maio, Massimo
    Del Giudice, Antonia
    De Feo, Gianfranco
    Bryce, Jane
    Lamura, Luana
    Vecchione, Aldo
    Normanno, Nicola
    Perrone, Francesco
    EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (02) : 299 - 307
  • [42] Toxicogenomics in drug discovery: from preclinical studies to clinical trials
    Yang, Y
    Blomme, EAG
    Waring, JF
    CHEMICO-BIOLOGICAL INTERACTIONS, 2004, 150 (01) : 71 - 85
  • [43] Potential of metabolomics in preclinical and clinical drug development
    Baldeep Kumar
    Ajay Prakash
    Rakesh Kumar Ruhela
    Bikash Medhi
    Pharmacological Reports, 2014, 66 : 956 - 963
  • [44] New anticancer drug development - Interim results of the cooperative programme between the Freiburg Preclinical Anticancer Drug Development Group and the EORTC New Drug Development Office
    Hendriks, HR
    Berger, DP
    Dengler, WA
    Drees, M
    Winterhalter, BR
    Lobbezoo, MW
    Fiebig, HH
    IMMUNODEFICIENT ANIMALS: MODELS FOR CANCER RESEARCH, 1996, 51 : 108 - 114
  • [45] Potential of metabolomics in preclinical and clinical drug development
    Kumar, Baldeep
    Prakash, Ajay
    Ruhela, Rakesh Kumar
    Medhi, Bikash
    PHARMACOLOGICAL REPORTS, 2014, 66 (06) : 956 - 963
  • [46] Human tumor xenograft models for preclinical assessment of anticancer drug development
    Jung J.
    Toxicological Research, 2014, 30 (1) : 1 - 5
  • [47] Methodology and limits of preclinical evaluation during the development of anticancer drug combinations
    Vassal, G
    BULLETIN DU CANCER, 1998, 85 (11) : 929 - 934
  • [48] Drug Development and Drug Approval
    Gaynor, Richard
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S139 - S140
  • [49] Role of non invasive animal imaging in preclinical anticancer drug development
    Guilbaud, N
    Duchamp, O
    Just, N
    Genne, P
    BULLETIN DU CANCER, 2005, 92 (01) : 45 - 57
  • [50] Genetically Engineered Mouse Models for Drug Development and Preclinical Trials
    Lee, Ho
    BIOMOLECULES & THERAPEUTICS, 2014, 22 (04) : 267 - 274
12345